Ontario Investing in Domestic Medical Technology Manufacturing To Ensure Future Preparedness | Ontario East

Ontario Investing in Domestic Medical Technology Manufacturing To Ensure Future Preparedness

News Release, May 25, 2021

Ottawa — The Ontario government is investing $2.5 million in Siemens Healthineers through the Ontario Together Fund. The investment will help increase production capacity of the epoc Blood Analysis System, a handheld device that can analyze oxygen levels in blood, helping clinicians make faster decisions with lab-quality results at the patient’s side. The project is expected to create 93 jobs over five years. To scale up their production capacity, Siemens Healthineers is investing over $20 million into their Ottawa facilities to increase their manufacturing output.

Innovative projects like this are why Ontario is investing an additional $50 million in the renewed Ontario Together Fund in 2021–22. The fund will continue supporting local businesses to further enhance Ontario’s domestic supply chain capacity, help us through the pandemic and ensure we are prepared for future challenges.

The renewed Ontario Together Fund will focus on supporting homegrown manufacturing and innovation to combat COVID-19 and provide other goods critical to the health, safety, and security of Ontarians beyond this pandemic under the following strategic pillars:

  • Strengthening Ontario’s domestic manufacturing capacity;
  • Supporting homegrown technologies and innovative solutions; and
  • Strengthening Ontario’s MedTech ecosystem.

“The renewed Ontario Together Fund will continue to strengthen our domestic manufacturing sector, support local innovators and boost our world-class MedTech ecosystem,” said Vic Fedeli, Minister of Economic Development, Job Creation and Trade. “Companies like Siemens Healthineers and their epoc Blood Analysis System are a perfect example of projects that can transform our ability to respond to a crisis and enhance our resilience while strengthening our health care system.”